SCHEMBL2915316

SCHEMBL2915316

O=C(c1ccc(Cl)cc1)c1coc2ccc(O)cc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 1.00
MAPT P10636 3/20 1.00
RAB9A P51151 3/20 1.00
LMNA P02545 3/20 1.00
HTT P42858 3/20 1.00
NFKB1 P19838 1/20 1.00
NFKB2 Q00653 1/20 1.00
RELA Q04206 1/20 1.00
CASP3 P42574 2/20 0.74
SENP7 Q9BQF6 2/20 0.74
SENP6 Q9GZR1 2/20 0.74
KMT2A Q03164 2/20 0.74
SENP8 Q96LD8 1/20 0.74
SMN1; SMN2 Q16637 1/20 0.69
SIRT1 Q96EB6 6/20 0.68
MAOA P21397 1/20 0.57
MAOB P27338 1/20 0.57
HPGD P15428 2/20 0.56
PTGS2 P35354 1/20 0.54
ALDH1A1 P00352 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL289145 0.85 SIRT1 (0.81) NPC1MAPTRAB9ALMNAHTT
SCHEMBL27861098 0.84 SIRT1 (0.84) NPC1MAPTRAB9ALMNAHTT
SCHEMBL289081 0.82 NPC1 (1.00) NPC1MAPTRAB9ALMNAHTT
SCHEMBL289885 0.77 SIRT1 (0.74) NPC1MAPTRAB9ALMNAHTT
SCHEMBL29630236 0.76 SIRT1 (0.66) NPC1MAPTRAB9ALMNAHTT
SCHEMBL3377499 0.76 SIRT1 (0.66) NPC1MAPTRAB9ALMNAHTT
SCHEMBL9594944 0.75 NPC1 (0.60) NPC1MAPTRAB9ALMNAHTT
SCHEMBL2916788 0.75 MAOB (0.68) NPC1MAPTRAB9ALMNAHTT
SCHEMBL289568 0.74 SIRT1 (0.70) NPC1MAPTRAB9ALMNAHTT
SCHEMBL31335179 0.73 SIRT1 (0.63) NPC1MAPTRAB9ALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065715-A1 Nogo Receptor Binding Small Molecules to Promote Axonal Growth YALE UNIVERSITY (US) 2011-03-17 US claimed
EP-2220499-A2 NOGO RECEPTOR BINDING SMALL MOLECULES TO PROMOTE AXONAL GROWTH Yale University (US) 2010-08-25 EP claimed
WO-2009073141-A2 NOGO RECEPTOR BINDING SMALL MOLECULES TO PROMOTE AXONAL GROWTH STRITTMATTER STEPHEN M (US) 2009-06-11 WO claimed
US-20110065715-A1 Nogo Receptor Binding Small Molecules to Promote Axonal Growth YALE UNIVERSITY (US) 2011-03-17 US disclosed
US-20110065715-A1 Nogo Receptor Binding Small Molecules to Promote Axonal Growth YALE UNIVERSITY (US) 2011-03-17 US disclosed
US-20110065715-A1 Nogo Receptor Binding Small Molecules to Promote Axonal Growth YALE UNIVERSITY (US) 2011-03-17 US disclosed
EP-2220499-A2 NOGO RECEPTOR BINDING SMALL MOLECULES TO PROMOTE AXONAL GROWTH Yale University (US) 2010-08-25 EP disclosed
WO-2009073141-A2 NOGO RECEPTOR BINDING SMALL MOLECULES TO PROMOTE AXONAL GROWTH STRITTMATTER STEPHEN M (US) 2009-06-11 WO disclosed
WO-2009073141-A2 NOGO RECEPTOR BINDING SMALL MOLECULES TO PROMOTE AXONAL GROWTH STRITTMATTER STEPHEN M (US) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065715-A1 Nogo Receptor Binding Small Molecules to Promote Axonal Growth NGFR, GAP43, BDNF NPC1 706/4885MAPT 333/4885RAB9A 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.